Cargando…

Transcriptomic profiling of Parkinson's disease brains reveals disease stage specific gene expression changes

Parkinson´s disease (PD) is a progressive neurodegenerative disorder characterized by both motor and non-motor symptoms. Aggravation of symptoms is mirrored by accumulation of protein aggregates mainly composed by alpha-synuclein in different brain regions, called Lewy bodies (LB). Previous studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cappelletti, Chiara, Henriksen, Sandra Pilar, Geut, Hanneke, Rozemuller, Annemieke J. M., van de Berg, Wilma D. J., Pihlstrøm, Lasse, Toft, Mathias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329075/ https://www.ncbi.nlm.nih.gov/pubmed/37347276 http://dx.doi.org/10.1007/s00401-023-02597-7

Ejemplares similares

APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease
por: Tunold, Jon-Anders, et al.
Publicado: (2021)

Allele-specific expression of Parkinson’s disease susceptibility genes in human brain
por: Langmyhr, Margrete, et al.
Publicado: (2021)

Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology
por: Pihlstrøm, Lasse, et al.
Publicado: (2022)

Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
por: Tunold, Jon-Anders, et al.
Publicado: (2023)

Epigenome-wide association study of peripheral immune cell populations in Parkinson’s disease
por: Andersen, Maren Stolp, et al.
Publicado: (2023)

Integrative analysis identifies bHLH transcription factors as contributors to Parkinson’s disease risk mechanisms
por: Berge-Seidl, Victoria, et al.
Publicado: (2021)

Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study
por: Bjørnarå, Kari Anne, et al.
Publicado: (2018)

Transcriptome and proteome profiling of neural stem cells from the human subventricular zone in Parkinson’s disease
por: Donega, Vanessa, et al.
Publicado: (2019)

Missense mutations in DYT-TOR1A dystonia
por: Iqbal, Zafar, et al.
Publicado: (2019)

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson’s Disease
por: Dijkstra, Anke A., et al.
Publicado: (2015)

Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literature
por: Ligaard, Johanne, et al.
Publicado: (2019)

Clinical and Pathological Phenotypes of LRP10 Variant Carriers with Dementia
por: Vergouw, Leonie J. M., et al.
Publicado: (2020)

Axonal degeneration in the anterior insular cortex is associated with Alzheimer’s co-pathology in Parkinson’s disease and dementia with Lewy bodies
por: Fathy, Yasmine Y., et al.
Publicado: (2022)

Dissecting the limited genetic overlap of Parkinson's and Alzheimer's disease
por: Stolp Andersen, Maren, et al.
Publicado: (2022)

Correction: Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia
por: Iqbal, Zafar, et al.
Publicado: (2017)

Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia
por: Iqbal, Zafar, et al.
Publicado: (2017)

Fine mapping of the HLA locus in Parkinson’s disease in Europeans
por: Yu, Eric, et al.
Publicado: (2021)

Copy number variation in Parkinson's disease
por: Toft, Mathias, et al.
Publicado: (2010)

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
por: Majbour, Nour, et al.
Publicado: (2022)

Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia
por: Frigerio, Irene, et al.
Publicado: (2023)

Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease
por: Keo, Arlin, et al.
Publicado: (2020)

Heritability Enrichment Implicates Microglia in Parkinson’s Disease Pathogenesis
por: Andersen, Maren Stolp, et al.
Publicado: (2021)

LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson’s disease and dementia with Lewy bodies
por: Grochowska, Martyna M., et al.
Publicado: (2021)

Aggravated stuttering following subthalamic deep brain stimulation in Parkinson's disease - two cases
por: Toft, Mathias, et al.
Publicado: (2011)

Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series
por: Geut, H., et al.
Publicado: (2020)

Transcriptomic analysis reveals an association of FCGBP with Parkinson’s disease
por: Gómez-Garre, Pilar, et al.
Publicado: (2022)

Structural (dys)connectivity associates with cholinergic cell density in Alzheimer’s disease
por: Lin, Chen Pei, et al.
Publicado: (2022)

Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease
por: Blauwendraat, Cornelis, et al.
Publicado: (2021)

Profile of cognitive impairment in late‐stage Parkinson's disease
por: Severiano e Sousa, Catarina, et al.
Publicado: (2022)

RIC3 variants are not associated with Parkinson’s disease in large European, Latin American, or East Asian cohorts
por: Brolin, Kajsa, et al.
Publicado: (2022)

Subthalamic deep brain stimulation improves sleep and excessive sweating in Parkinson’s disease
por: Bjerknes, Silje, et al.
Publicado: (2020)

Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease
por: Hoozemans, Jeroen JM, et al.
Publicado: (2005)

Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
por: Moors, Tim E., et al.
Publicado: (2017)

Classification of Parkinson's disease stages with a two-stage deep neural network
por: Pedrero-Sánchez, José Francisco, et al.
Publicado: (2023)

Differential insular cortex subregional vulnerability to α‐synuclein pathology in Parkinson's disease and dementia with Lewy bodies
por: Fathy, Y. Y., et al.
Publicado: (2018)

Impact of Parkinson’s Disease on Functional Mobility at Different Stages
por: Mollà-Casanova, Sara, et al.
Publicado: (2022)

Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer’s Disease Pathology
por: Rosenberger, Andrea F.N., et al.
Publicado: (2015)

Classification of Parkinson’s disease and its stages using machine learning
por: Templeton, John Michael, et al.
Publicado: (2022)

Neuroinflammation in Alzheimer's disease wanes with age
por: Hoozemans, Jeroen JM, et al.
Publicado: (2011)

Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4b9vm38o8kpkifgitmkkenc9og